UTAH MED. PRODS DL-01
Utah Medical Products, Inc. provides medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. The company also provides GESCO, an umbilical vessel catheter, including DIALY-NATE disposable peritoneal … Read more
UTAH MED. PRODS DL-01 (UTM) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, UTAH MED. PRODS DL-01 (UTM) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
UTAH MED. PRODS DL-01 - Net Assets Trend (None–None)
This chart illustrates how UTAH MED. PRODS DL-01's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for UTAH MED. PRODS DL-01 (None–None)
The table below shows the annual net assets of UTAH MED. PRODS DL-01 from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to UTAH MED. PRODS DL-01's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
UTAH MED. PRODS DL-01 Competitors by Market Cap
The table below lists competitors of UTAH MED. PRODS DL-01 ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Rongcheer Industrial Technology (Suzhou) Co. Ltd. A
SHE:301360
|
$155.21 Million |
|
Electromed Inc
NYSE MKT:ELMD
|
$155.30 Million |
|
Komplett Bank ASA
F:KBN
|
$155.32 Million |
|
Colombier Acquisition Corp. II
NYSE:CLBR
|
$155.33 Million |
|
AO World plc
F:81A
|
$155.05 Million |
|
Newbury Street II Acquisition Corp Unit
NASDAQ:NTWOU
|
$155.05 Million |
|
Beijing Jiaman Dress Co. Ltd. A
SHE:301276
|
$155.01 Million |
|
Fujian South Highway Machinery Co. Ltd. A
SHG:603280
|
$154.99 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in UTAH MED. PRODS DL-01's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares UTAH MED. PRODS DL-01's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently UTAH MED. PRODS DL-01 utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares UTAH MED. PRODS DL-01's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $9,394,036,854
- Average return on equity (ROE) among peers: 4.98%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| UTAH MED. PRODS DL-01 (UTM) | €- | N/A | N/A | $155.19 Million |
| Modern Dental Group Limited (1MD) | $2.36 Billion | 15.30% | 0.55x | $193.75 Million |
| SCHOTT Pharma AG & Co. KGaA (1SXP) | $709.04 Million | 17.68% | 0.69x | $482.88 Million |
| Alcon Inc. (2U3) | $19.26 Billion | 1.95% | 0.45x | $33.73 Billion |
| Shofu Inc. (69W) | $35.51 Billion | 8.83% | 0.23x | $215.32 Million |
| 7VG (7VG) | $176.36 Million | 14.92% | 1.12x | $684.88 Million |
| Bio-gate AG (BIG1) | $4.25 Million | -42.46% | 0.46x | $2.79 Million |
| Paul Hartmann AG (PHH2) | $690.37 Million | 10.65% | 0.81x | $776.29 Million |
| Sartorius AG VZO O.N. (SRT) | $497.08 Million | 9.76% | 1.56x | $6.78 Billion |
| Shandong Weigao Group Medical Polymer Company Limited (UK2) | $25.34 Billion | 8.16% | 0.37x | $1.36 Billion |